Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Mitochondrial disease

Gene: SLC25A20

Green List (high evidence)

SLC25A20 (solute carrier family 25 member 20)
EnsemblGeneIds (GRCh38): ENSG00000178537
EnsemblGeneIds (GRCh37): ENSG00000178537
OMIM: 613698, Gene2Phenotype
SLC25A20 is in 10 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Carnitine-acylcarnitine translocase deficiency is a rare autosomal recessive metabolic disorder of long-chain fatty acid oxidation. Metabolic consequences include hypoketotic hypoglycemia under fasting conditions, hyperammonemia, elevated creatine kinase and transaminases, dicarboxylic aciduria, very low free carnitine and abnormal acylcarnitine profile with marked elevation of the long-chain acylcarnitines. Clinical features include neurologic abnormalities, cardiomyopathy and arrhythmias, skeletal muscle damage, and liver dysfunction. Most patients become symptomatic in the neonatal period with a rapidly progressive deterioration and a high mortality rate. However, presentations at a later age with a milder phenotype have been reported. Well established gene-disease association.
Created: 30 Dec 2020, 9:49 p.m. | Last Modified: 30 Dec 2020, 9:49 p.m.
Panel Version: 0.5879

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Carnitine-acylcarnitine translocase deficiency, MIM# 212138

Publications

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

>3 cases. Condition is a recessive disorder of mitochondrial fatty acid oxidation.
Sources: Literature, NHS GMS
Created: 20 Mar 2020, 8:19 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Carnitine-acylcarnitine translocase deficiency MIM#212138

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Expert Review Green
  • NHS GMS
  • Literature
  • Victorian Clinical Genetics Services
Phenotypes
  • Carnitine-acylcarnitine translocase deficiency MIM#212138
Tags
treatable
OMIM
613698
Clinvar variants
Variants in SLC25A20
Penetrance
None
Publications
Panels with this gene

History Filter Activity

29 Sep 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag treatable tag was added to gene: SLC25A20.

20 Mar 2020, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: slc25a20 has been classified as Green List (High Evidence).

20 Mar 2020, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: slc25a20 has been classified as Green List (High Evidence).

20 Mar 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: SLC25A20 was added gene: SLC25A20 was added to Mitochondrial disease. Sources: Literature,NHS GMS Mode of inheritance for gene: SLC25A20 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC25A20 were set to 9399886; 31108048; 25778941 Phenotypes for gene: SLC25A20 were set to Carnitine-acylcarnitine translocase deficiency MIM#212138 Review for gene: SLC25A20 was set to GREEN